Optimizing the management of HER2-negative metastatic breast cancer in the era of PARP inhibitors-proceedings from breast cancer expert group meeting
Chinese clinical oncology（2020）
Key words
Human epidermal growth factor receptor,breast cancer,BRCA mutations,poly-ADP ribose polymerase inhibitors (PARPi),immunotherapy
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined